Clinical Trial Update: Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating liposomal vincristine in pediatric and adolescent patients with relapsed malignancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Osteosarcoma
• Soft Tissue Sarcoma
• Wilms Tumor

Drugs mentioned

• Liposomal vincristine (vincristine liposome)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Soft Tissue Sarcoma, Lymphoma | Phase 2 | Status: COMPLETED